Reducing the Diagnostic Heterogeneity of Schizoaffective Disorder

Clinical outcome studies of schizoaffective disorder patients have yielded conflicting results. One reason is the heterogeneity of samples drawn from the schizoaffective disorder population. Here, we studied schizoaffective disorder patients who showed marked functional impairment and continuous sig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in psychiatry 2017-02, Vol.8, p.18-18
Hauptverfasser: Seldin, Katherine, Armstrong, Kristan, Schiff, Max L, Heckers, Stephan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 18
container_issue
container_start_page 18
container_title Frontiers in psychiatry
container_volume 8
creator Seldin, Katherine
Armstrong, Kristan
Schiff, Max L
Heckers, Stephan
description Clinical outcome studies of schizoaffective disorder patients have yielded conflicting results. One reason is the heterogeneity of samples drawn from the schizoaffective disorder population. Here, we studied schizoaffective disorder patients who showed marked functional impairment and continuous signs of illness for at least 6 months (i.e., DSM criteria B and C for schizophrenia). We assessed 176 chronic psychosis patients with a structured interview (SCID-IV-TR) and the Diagnostic Interview for Genetic Studies schizoaffective disorder module. We diagnosed 114 patients with schizophrenia and 62 with schizoaffective disorder. The two groups were similar with regard to age, gender, and race. We tested for group differences in antecedent risk factors, clinical features, and functional outcome. The schizoaffective disorder group differed from the schizophrenia group on two measures only: they showed higher rates of suicidality (more suicide attempts,  
doi_str_mv 10.3389/fpsyt.2017.00018
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5300988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1872583057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-c9ff54a0735fb4af0ced9fa752d3e3d545237b8a62c8c9d6cee727674e068d1d3</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMoWqp7VzJLN1MzyeQxG0HqEwTBxzqkyU0bmU5qkhbqr3daq-jqHrjnnHv5EDqt8IhS2Vy4RVrnEcGVGGGMK7mHBhXndYl5jff_6CN0ktJ7b8G0aShnh-iISEJ7SQbo6hns0vhuWuQZFNdeT7uQsjfFPWSIYQod-LwugitezMx_Bu0cmOxXG28K0UI8RgdOtwlOdnOI3m5vXsf35ePT3cP46rE0tOG5NI1zrNZYUOYmtXbYgG2cFoxYCtSymhEqJlJzYqRpLDcAggguasBc2srSIbr87l0sJ3OwBrocdasW0c91XKugvfq_6fxMTcNKMYpxI2VfcL4riOFjCSmruU8G2lZ3EJZJVVIQJilmorfib6uJIaUI7vdMhdUGvtrCVxv4agu_j5z9fe838IOafgEec4Ls</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1872583057</pqid></control><display><type>article</type><title>Reducing the Diagnostic Heterogeneity of Schizoaffective Disorder</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Seldin, Katherine ; Armstrong, Kristan ; Schiff, Max L ; Heckers, Stephan</creator><creatorcontrib>Seldin, Katherine ; Armstrong, Kristan ; Schiff, Max L ; Heckers, Stephan</creatorcontrib><description>Clinical outcome studies of schizoaffective disorder patients have yielded conflicting results. One reason is the heterogeneity of samples drawn from the schizoaffective disorder population. Here, we studied schizoaffective disorder patients who showed marked functional impairment and continuous signs of illness for at least 6 months (i.e., DSM criteria B and C for schizophrenia). We assessed 176 chronic psychosis patients with a structured interview (SCID-IV-TR) and the Diagnostic Interview for Genetic Studies schizoaffective disorder module. We diagnosed 114 patients with schizophrenia and 62 with schizoaffective disorder. The two groups were similar with regard to age, gender, and race. We tested for group differences in antecedent risk factors, clinical features, and functional outcome. The schizoaffective disorder group differed from the schizophrenia group on two measures only: they showed higher rates of suicidality (more suicide attempts,  &lt; 0.01; more hospitalizations to prevent suicide,  &lt; 0.01) and higher anxiety disorder comorbidity (  &lt; 0.01). When schizoaffective disorder patients meet DSM criteria B and C for schizophrenia, they resemble schizophrenia patients on several measures used to assess validity. The increased rate of anxiety disorders and suicidality warrants clinical attention. Our data suggest that a more explicit definition of schizoaffective disorder reduces heterogeneity and may increase validity.</description><identifier>ISSN: 1664-0640</identifier><identifier>EISSN: 1664-0640</identifier><identifier>DOI: 10.3389/fpsyt.2017.00018</identifier><identifier>PMID: 28239362</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Psychiatry</subject><ispartof>Frontiers in psychiatry, 2017-02, Vol.8, p.18-18</ispartof><rights>Copyright © 2017 Seldin, Armstrong, Schiff and Heckers. 2017 Seldin, Armstrong, Schiff and Heckers</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-c9ff54a0735fb4af0ced9fa752d3e3d545237b8a62c8c9d6cee727674e068d1d3</citedby><cites>FETCH-LOGICAL-c396t-c9ff54a0735fb4af0ced9fa752d3e3d545237b8a62c8c9d6cee727674e068d1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300988/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300988/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28239362$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seldin, Katherine</creatorcontrib><creatorcontrib>Armstrong, Kristan</creatorcontrib><creatorcontrib>Schiff, Max L</creatorcontrib><creatorcontrib>Heckers, Stephan</creatorcontrib><title>Reducing the Diagnostic Heterogeneity of Schizoaffective Disorder</title><title>Frontiers in psychiatry</title><addtitle>Front Psychiatry</addtitle><description>Clinical outcome studies of schizoaffective disorder patients have yielded conflicting results. One reason is the heterogeneity of samples drawn from the schizoaffective disorder population. Here, we studied schizoaffective disorder patients who showed marked functional impairment and continuous signs of illness for at least 6 months (i.e., DSM criteria B and C for schizophrenia). We assessed 176 chronic psychosis patients with a structured interview (SCID-IV-TR) and the Diagnostic Interview for Genetic Studies schizoaffective disorder module. We diagnosed 114 patients with schizophrenia and 62 with schizoaffective disorder. The two groups were similar with regard to age, gender, and race. We tested for group differences in antecedent risk factors, clinical features, and functional outcome. The schizoaffective disorder group differed from the schizophrenia group on two measures only: they showed higher rates of suicidality (more suicide attempts,  &lt; 0.01; more hospitalizations to prevent suicide,  &lt; 0.01) and higher anxiety disorder comorbidity (  &lt; 0.01). When schizoaffective disorder patients meet DSM criteria B and C for schizophrenia, they resemble schizophrenia patients on several measures used to assess validity. The increased rate of anxiety disorders and suicidality warrants clinical attention. Our data suggest that a more explicit definition of schizoaffective disorder reduces heterogeneity and may increase validity.</description><subject>Psychiatry</subject><issn>1664-0640</issn><issn>1664-0640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLAzEUhYMoWqp7VzJLN1MzyeQxG0HqEwTBxzqkyU0bmU5qkhbqr3daq-jqHrjnnHv5EDqt8IhS2Vy4RVrnEcGVGGGMK7mHBhXndYl5jff_6CN0ktJ7b8G0aShnh-iISEJ7SQbo6hns0vhuWuQZFNdeT7uQsjfFPWSIYQod-LwugitezMx_Bu0cmOxXG28K0UI8RgdOtwlOdnOI3m5vXsf35ePT3cP46rE0tOG5NI1zrNZYUOYmtXbYgG2cFoxYCtSymhEqJlJzYqRpLDcAggguasBc2srSIbr87l0sJ3OwBrocdasW0c91XKugvfq_6fxMTcNKMYpxI2VfcL4riOFjCSmruU8G2lZ3EJZJVVIQJilmorfib6uJIaUI7vdMhdUGvtrCVxv4agu_j5z9fe838IOafgEec4Ls</recordid><startdate>20170210</startdate><enddate>20170210</enddate><creator>Seldin, Katherine</creator><creator>Armstrong, Kristan</creator><creator>Schiff, Max L</creator><creator>Heckers, Stephan</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170210</creationdate><title>Reducing the Diagnostic Heterogeneity of Schizoaffective Disorder</title><author>Seldin, Katherine ; Armstrong, Kristan ; Schiff, Max L ; Heckers, Stephan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-c9ff54a0735fb4af0ced9fa752d3e3d545237b8a62c8c9d6cee727674e068d1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seldin, Katherine</creatorcontrib><creatorcontrib>Armstrong, Kristan</creatorcontrib><creatorcontrib>Schiff, Max L</creatorcontrib><creatorcontrib>Heckers, Stephan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Frontiers in psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seldin, Katherine</au><au>Armstrong, Kristan</au><au>Schiff, Max L</au><au>Heckers, Stephan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reducing the Diagnostic Heterogeneity of Schizoaffective Disorder</atitle><jtitle>Frontiers in psychiatry</jtitle><addtitle>Front Psychiatry</addtitle><date>2017-02-10</date><risdate>2017</risdate><volume>8</volume><spage>18</spage><epage>18</epage><pages>18-18</pages><issn>1664-0640</issn><eissn>1664-0640</eissn><abstract>Clinical outcome studies of schizoaffective disorder patients have yielded conflicting results. One reason is the heterogeneity of samples drawn from the schizoaffective disorder population. Here, we studied schizoaffective disorder patients who showed marked functional impairment and continuous signs of illness for at least 6 months (i.e., DSM criteria B and C for schizophrenia). We assessed 176 chronic psychosis patients with a structured interview (SCID-IV-TR) and the Diagnostic Interview for Genetic Studies schizoaffective disorder module. We diagnosed 114 patients with schizophrenia and 62 with schizoaffective disorder. The two groups were similar with regard to age, gender, and race. We tested for group differences in antecedent risk factors, clinical features, and functional outcome. The schizoaffective disorder group differed from the schizophrenia group on two measures only: they showed higher rates of suicidality (more suicide attempts,  &lt; 0.01; more hospitalizations to prevent suicide,  &lt; 0.01) and higher anxiety disorder comorbidity (  &lt; 0.01). When schizoaffective disorder patients meet DSM criteria B and C for schizophrenia, they resemble schizophrenia patients on several measures used to assess validity. The increased rate of anxiety disorders and suicidality warrants clinical attention. Our data suggest that a more explicit definition of schizoaffective disorder reduces heterogeneity and may increase validity.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>28239362</pmid><doi>10.3389/fpsyt.2017.00018</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-0640
ispartof Frontiers in psychiatry, 2017-02, Vol.8, p.18-18
issn 1664-0640
1664-0640
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5300988
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; PubMed Central; EZB Electronic Journals Library
subjects Psychiatry
title Reducing the Diagnostic Heterogeneity of Schizoaffective Disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A26%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reducing%20the%20Diagnostic%20Heterogeneity%20of%20Schizoaffective%20Disorder&rft.jtitle=Frontiers%20in%20psychiatry&rft.au=Seldin,%20Katherine&rft.date=2017-02-10&rft.volume=8&rft.spage=18&rft.epage=18&rft.pages=18-18&rft.issn=1664-0640&rft.eissn=1664-0640&rft_id=info:doi/10.3389/fpsyt.2017.00018&rft_dat=%3Cproquest_pubme%3E1872583057%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1872583057&rft_id=info:pmid/28239362&rfr_iscdi=true